ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 28 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,412 | -56.8% | 20,000 | 0.0% | 0.00% | – |
Q4 2022 | $3,268 | -18.3% | 20,000 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | +33.3% | 20,000 | 0.0% | 0.00% | – |
Q2 2022 | $3,000 | -57.1% | 20,000 | 0.0% | 0.00% | – |
Q1 2022 | $7,000 | -63.2% | 20,000 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $19,000 | +5.6% | 20,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $18,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ANGELO GORDON & CO., L.P. | 60,000 | $603,000 | 0.11% |
GRITSTONE ASSET MANAGEMENT LLC | 276,000 | $41,869 | 0.05% |
Anson Funds Management LP | 15,000 | $150,750 | 0.02% |
Radcliffe Capital Management, L.P. | 80,001 | $804,010 | 0.02% |
Segantii Capital Management Ltd | 30,000 | $302,000 | 0.01% |
Arena Capital Advisors, LLC- CA | 111,314 | $16,886 | 0.01% |
PERISCOPE CAPITAL INC. | 383,533 | $58,942 | 0.00% |
683 Capital Management, LLC | 239,800 | $36,378 | 0.00% |
Atalaya Capital Management LP | 100,000 | $15,000 | 0.00% |
Kepos Capital LP | 80,000 | $12 | 0.00% |